Lundbeck
HLUN-B.CO
#2629
Rank
โ‚น584.91 B
Marketcap
โ‚น616.30
Share price
-0.32%
Change (1 day)
27.10%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): โ‚น52.79

According to Lundbeck's latest financial reports the company's current EPS (TTM) is โ‚น55.73. In 2024 the company made an earnings per share (EPS) of โ‚น40.25 an increase over its 2023 EPS that were of โ‚น31.13.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น52.7931.16%
2024โ‚น40.2529.29%
2023โ‚น31.1323.09%
2022โ‚น25.2937.26%
2021โ‚น18.42-84.61%
2020โ‚น119.72-24.61%
2019โ‚น158.80-42.06%
2018โ‚น274.0740.7%
2017โ‚น194.80146.26%
2016โ‚น79.10-120.48%
2015-โ‚น386.163231.32%
2014-โ‚น11.59-115.78%
2013โ‚น73.45-23.36%
2012โ‚น95.84-48.01%
2011โ‚น184.35-9.68%
2010โ‚น204.1213.72%
2009โ‚น179.4924.32%
2008โ‚น144.38-6.05%
2007โ‚น153.6781.77%
2006โ‚น84.54-16.76%
2005โ‚น101.57-17.58%
2004โ‚น123.24